The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder?-Reference-Cited by-同舟云学术

The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder?

Published:2019-12-19 Issue:1 Volume:53 Page:172-182
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:Eur J Neurosci

Author:

Nothdurfter Caroline¹,Milenkovic Vladimir M.¹^ORCID,Sarubin Nina¹²³,Hilbert Sven⁴,Manook André¹,Weigl Johannes¹,Almeqbaali Khalifa¹,Wetzel Christian H.¹,Rupprecht Rainer¹,Baghai Thomas C.¹

Affiliation:

1. Department of Psychiatry and Psychotherapy University of Regensburg Regensburg Germany

2. Hochschule Fresenius University of Applied Sciences Munich Germany

3. Department of Psychology, Psychological Methods and Assessment Ludwig‐Maximilians‐Universität Munich Germany

4. Faculty of Psychology, Educational Science and Sport Science University of Regensburg Regensburg Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejn.14636

Reference67 articles.

1. IL-17 Signaling: The Yin and the Yang

2. VEGF in Signaling and Disease: Beyond Discovery and Development

3. Fitting Linear Mixed-Effects Models Usinglme4

4. Chronic depression is associated with a pronounced decrease in serum brain-derived neurotrophic factor over time

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors;Brain, Behavior, & Immunity - Health;2024-07

2. Immune-Targeted Therapies for Depression;The Journal of Clinical Psychiatry;2024-06-24

3. Integrated analysis of transcriptional changes in major depressive disorder: Insights from blood and anterior cingulate cortex;Heliyon;2024-04

4. Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile;BMC Psychiatry;2024-01-31

5. Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder;Scientific Reports;2024-01-18